Palatin Technologies
PTN
#10824
Rank
HK$0.12 B
Marketcap
HK$70.71
Share price
-5.36%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -HK$48.8 Million

According to Palatin Technologies's latest financial reports the company's current earnings are HK$12.88 Million. In 2025 the company made an earning of -HK$75.5 Million, an increase over its 2024 earnings that were of -HK$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$48.8 Million-35.36%
2025 -HK$75.5 Million-64.29%
2024 -HK$0.22 Billion-16.9%
2023 -HK$0.26 Billion5.99%
2022 -HK$0.25 Billion-13.7%
2021 -HK$0.28 Billion33.25%
2020 -HK$0.21 Billion-172.11%
2019 HK$0.28 B2352.33%
2018 HK$11.8 M-94.13%
2017 HK$0.20 B-154.92%
2016 -HK$0.37 Billion3.67%
2015 -HK$0.36 Billion878%
2014 -HK$36.12 Million-72.64%
2013 -HK$0.14 Billion-33.11%
2012 -HK$0.2 Billion77.71%
2011 -HK$0.12 Billion
2003 -HK$0.19 Billion29.93%
2002 -HK$0.15 Billion36.18%
2001 -HK$0.11 Billion
1999 -HK$88.21 Million6.04%
1998 -HK$83.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$205.67 B-419,974.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$112.47 B-229,711.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$6.42 B-13,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$84.34 Million 72.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$1.91 B-4,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-HK$0.93 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$1.11 B-2,384.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-HK$0.24 Billion 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$0.44 Billion 788.76%๐Ÿ‡บ๐Ÿ‡ธ USA